Christopher N. Toepfer
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy.
Journal: JACC. Basic to translational science
Published: February 13, 2026
Desmoglein-2 deficiency results in cardiac dysfunction by compromising both Z-disc- and intercalated disc-mediated mechanotransduction.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy.
Journal: British journal of pharmacology
Published: May 23, 2025
Microscale droplet assembly enables biocompatible multifunctional modular iontronics.
Journal: Science (New York, N.Y.)
Published: November 28, 2024
Assaying the myosin super-relaxed state across muscle types, cells and proteins for understanding muscle biology and use in drug discovery.
Journal: Nature protocols
Published: June 07, 2024
Regulation of sarcomere formation and function in the healthy heart requires a titin intronic enhancer.
Journal: The Journal of clinical investigation
Published: June 04, 2024
Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C+/- During Development.
Journal: bioRxiv : the preprint server for biology
Published: August 23, 2023
Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes.
Journal: Journal of molecular and cellular cardiology
Published: November 25, 2022
Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation.
Journal: Frontiers in cellular and infection microbiology
Published: November 14, 2022
Last Updated: 09/26/2026